Correlation Between Cisco Systems and Catalyst Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cisco Systems and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cisco Systems and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Cisco Systems and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and Catalyst Pharmaceuticals.

Diversification Opportunities for Cisco Systems and Catalyst Pharmaceuticals

-0.35

Correlation Coefficient

Cisco Systems  Catalyst Pharmaceuticals

Very good diversification

The 3 months correlation between Cisco and Catalyst is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Cisco Systems i.e., Cisco Systems and Catalyst Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cisco Systems and Catalyst Pharmaceuticals

Given the investment horizon of 90 days Cisco Systems is expected to generate 0.6 times more return on investment than Catalyst Pharmaceuticals. However, Cisco Systems is 1.67 times less risky than Catalyst Pharmaceuticals. It trades about 0.32 of its potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  5,471  in Cisco Systems on April 22, 2025 and sell it today you would earn a total of  1,334  from holding Cisco Systems or generate 24.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cisco Systems  vs.  Catalyst Pharmaceuticals

Cisco Systems

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Cisco Systems displayed solid returns over the last few months and may actually be approaching a breakup point.

Catalyst Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Catalyst Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Catalyst Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cisco Systems and Catalyst Pharmaceuticals

The main advantage of trading using opposite Cisco Systems and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.

The idea behind Cisco Systems and Catalyst Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.